Evidence map›Paper›PMID 35179037›Full record

Trial reportJournal of the American Heart Association2022

Grayscale Ultrasound Texture Features of Carotid and Brachial Arteries in People With HIV Infection Before and After Antiretroviral Therapy.

Christina M Hughey, Belinda W Vuong, Heather B Ribaudo, Carol C K Mitchell, Claudia E Korcarz, Howard N Hodis, Judith S Currier, James H Stein

Open access · goldAbstract readClinical Trial
In one paragraph

Trial report in Journal of the American Heart Association, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 97% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Christina M HugheyUniversity of Wisconsin School of Medicine and Public Health Madison WI.
Belinda W VuongUniversity of Wisconsin School of Medicine and Public Health Madison WI.
Heather B RibaudoHarvard T.H. Chan School of Public Health Boston MA.
Carol C K MitchellUniversity of Wisconsin School of Medicine and Public Health Madison WI.ORCID 0000-0001-6445-3306
Claudia E KorcarzUniversity of Wisconsin School of Medicine and Public Health Madison WI.ORCID 0000-0001-9691-9027
Howard N HodisKeck School of Medicine of University of Southern California Los Angeles CA.
Judith S CurrierDavid Geffen School of Medicine at University of California-Los Angeles Los Angeles CA.
James H SteinUniversity of Wisconsin School of Medicine and Public Health Madison WI.ORCID 0000-0002-2770-8223
University of Wisconsin–Madison · USHarvard University · USUniversity of California, Los Angeles · USUniversity of Southern California · US

Funding

Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/UM1AI068636 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Joseph J Eron, RAJESH T GANDHI · 2011 to 2026
$1073.1M
Statistical and Data Management Center (SDMC), AIDS Clinical Trials Group (ACTG)UM1AI068634 · NIAID · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI Marlene Ann Cooper, Michael David Hughes · 2011 to 2026
$246.6M
AIDS Clinical Trials Group NetworkU01AI068636 · NIAID · SOCIAL AND SCIENTIFIC SYSTEMS, INC. · PI KURITZKES, DANIEL R. · 2006 to 2010
$147.1M
Validation, CLIA and Qualification (VQC): Enhancing the RS ratio as a tool for AIDS Clinical Trial Group (ACTG) tuberculosis trialsUM1AI106701 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Grace M Aldrovandi · 2014 to 2026
$116.8M
Statistical and Data Management Center for the AIDS Clinical Trials GroupU01AI068634 · NIAID · HARVARD SCHOOL OF PUBLIC HEALTH · PI HUGHES, MICHAEL DAVID · 2006 to 2010
$71.9M
UCLA AIDS Prevention and Treatment Clinical Trials UnitUM1AI069424 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Judith S. Currier, RAPHAEL J LANDOVITZ · 2012 to 2026
$51.8M
Northwestern University Clinical Trial UnitUM1AI069471 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Chad J Achenbach · 2012 to 2026
$24.6M
Northwestern University Clinical Trial UnitU01AI069471 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI MURPHY, ROBERT LEO · 2007 to 2011
$12.0M
CVD and Metabolic Complications of HIV/AIDS Data Coordinating CenterR01HL095126 · NHLBI · UNIVERSITY OF WASHINGTON · PI KRONMAL, RICHARD A · 2008 to 2012
$5.9M
Prospective Evaluation of Antiviral Therapy and Cardiac HealthR01HL095132 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CURRIER, JUDITH S., STEIN, JAMES H · 2008 to 2012
$4.0M
Optimizing Antiretroviral Therapy in HIV K24AI056933 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CURRIER, JUDITH S. · 2003 to 2013
$1.4M
Effects of HIV Infection and HIV Disease Measures on Arterial FunctionR21HL146199 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI STEIN, JAMES H · 2019 to 2020
$256k
NHLBI NIH HHS R01 HL095126NHLBI NIH HHS R01 HL095132NHLBI NIH HHS R21 HL146199NIAID NIH HHS K24 AI056933NIAID NIH HHS U01 AI068634NIAID NIH HHS U01 AI068636NIAID NIH HHS U01 AI069471NIAID NIH HHS UM1 AI068634NIAID NIH HHS UM1 AI068636NIAID NIH HHS UM1 AI069424NIAID NIH HHS UM1 AI069471NIAID NIH HHS UM1 AI106701NIH HHS S10 OD010569
6 · The paper itself

Abstract

Background We aimed to investigate novel grayscale ultrasound characteristics of the carotid and brachial arteries in people with HIV infection before and after starting initial antiretroviral therapy (ART). Methods and Results We performed grayscale ultrasound image analyses of the common carotid artery (CCA) and brachial artery before and after receipt of 1 of 3 randomly allocated ART regimens. We measured arterial wall echogenicity (grayscale median), contrast (gray-level difference statistic method), and entropy. These measures and their changes were compared with atherosclerotic cardiovascular disease risk factors, measures of HIV disease severity, and inflammatory biomarkers before and after ART. Changes in the grayscale measures were evaluated within and between ART arms. Among 201 ART-naïve people with HIV, higher systolic blood pressure, higher body mass index, lower CD4+ T cells, and non-Hispanic White race and ethnicity were associated independently with lower CCA grayscale median. Changes in each CCA grayscale measure from baseline to 144 weeks correlated with changes in soluble CD163: grayscale median (ρ=-0.17;

Indexed as

AtherosclerosisCardiovascular DiseasesHIV InfectionsBrachial ArteryCarotid ArteriesHumansPredictive Value of TestsUltrasonographyantiretroviral therapyatherosclerosisbrachial arteriescarotid arteriesHIVultrasoundvascular disease

Identifiers

PMID35179037
PMCPMC9075086
OpenAlexW4212862368

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.